Leviathan Cannabis Group Inc Aktie Canadian Securities Exchange
Aktien
CA61762Y1051
Pharmazeutika
Umsatz 2022 | 842’491 616’518 560’644 | Umsatz 2023 | 35.34 Mio. 25.86 Mio. 23.52 Mio. | Marktwert | 219 Mio. 160 Mio. 145 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2022 | -4 Mio. -2.93 Mio. -2.66 Mio. | Nettoergebnis 2023 | - 0 0 | EV / Sales 2022 | 150 x |
Nettoschuld 2022 | 8.9 Mio. 6.51 Mio. 5.92 Mio. | Nettoschuld 2023 | 3.32 Mio. 2.43 Mio. 2.21 Mio. | EV / Sales 2023 | 6.28 x |
KGV 2022 |
-23.4
x | KGV 2023 |
-238
x | Beschäftigte | - |
Rendite 2022 * |
-
| Rendite 2023 |
-
| Streubesitz | 87.12% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07.03.22 |
Director of Finance/CFO | - | 07.03.22 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07.03.22 |
Rupalee Mehta
BRD | Director/Board Member | - | 07.03.22 |
Lucas Leone
BRD | Director/Board Member | - | 07.03.22 |
% 1. Jan. | Kap. | |
---|---|---|
+29.68% | 699 Mrd. | |
+25.07% | 571 Mrd. | |
-4.35% | 364 Mrd. | |
+17.65% | 326 Mrd. | |
+3.77% | 286 Mrd. | |
+14.68% | 236 Mrd. | |
+4.71% | 198 Mrd. | |
-12.43% | 194 Mrd. | |
-3.79% | 154 Mrd. |